
Sign up to save your podcasts
Or


Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
By American Academy of Neurology4.8
132132 ratings
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

317 Listeners

496 Listeners

296 Listeners

50 Listeners

295 Listeners

3,339 Listeners

12 Listeners

1,151 Listeners

23 Listeners

194 Listeners

92 Listeners

512 Listeners

366 Listeners

190 Listeners

81 Listeners